Methylphenidate (MPH) is a first line drug for attention-deficit/hyperactivity disorder (ADHD). yet the neuronal mechanisms underlying the condition and the treatment are still not fully understood. Previous EEG studies on the effect of MPH in ADHD found changes in evoked response potential (ERP) components that were inconsistent between studies. These inconsistencies highlight the ne... https://halohealthcarers.shop/product-category/lifts/